Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
发生了什么
Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.
摘要按规则整理自下方来源原文
Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.
摘要按规则整理自下方来源原文